Adjuvant immunotherapy of high risk stage I melanoma with transfer factor

Cancer

Volumn 47, Issue 5, 1981, Pages 882-888

  Blume, Myron R ^a   Rosenbaum, Ernest H ^a   Cohen, Richard J ^a   Gershow, Jay ^a   Glassberg, Alan B ^a   Shepley, Eileen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; TRANSFER FACTOR;

CANCER IMMUNOTHERAPY; CANCER SURGERY; DRUG THERAPY; MELANOMA; THERAPY;

ADOLESCENT; ADULT; AGED; CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MALE; MELANOMA; MIDDLE AGED; RECURRENCE; RISK; SKIN NEOPLASMS; TRANSFER FACTOR;

EID: 0019506184     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19810301)47:5<882::AID-CNCR2820470512>3.0.CO;2-E     Document Type: Article

References (46)

1. A multifactorial analysis of melanoma. Prognostic histopathological features comparing Clark's and Breslow's staging methods
2. Does transfer factor act specifically or as an immunologic adjuvant?
3. A comparison of BCG with transfer factor (TF) in adjuvant immunotherapy of Stage II malignant melanoma
4. Tumor thickness, level of invasion and node dissection in Stage I cutaneous melanoma
5. Long‐term spontaneous regression of malignant melanoma with visceral metastases
6. The histogenesis and biologic behavior of primary human malignant melanomas of the skin
7. Treatment of malignant melanoma: wide excision alone vs. lymphadenectomy
8. Cutaneous melanoma: the Queensland experience
9. The Henry Joseph Windsor lecture: Melanoma is a word, not a sentence
10. Effect of transfer factor therapy on mixed lymphocyte culture reactivity
11. Malignant melanoma: treatment by endolymphatic radio‐isotope infusion
12. Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma
13. Editorial. Historical controls reincarnated: an examination of techniques for clinical therapeutic research
14. Non‐randomized controls in cancer clinical trials
15. Prognostic significance of lymph node dissection in the treatment of malignant melanoma
16. Results of regional lymph node dissection for melanoma
17. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazene imidazole carboxamide and bacillus Calmette‐Guérin
18. Immunology and immunotherapy of human malignant melanoma: historic review and perspectives for the future
19. Hunterian lectures on the pathology of melanotic growth in relation to their operative treatment
20. Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck
21. Melanoma
22. Antibody‐dependent cell‐mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells
23. Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes
24. The transfer of generalized cutaneous hypersensitivity of the delayed tuberculin type in man by means of the constituents of disrupted leukocytes
25. Transfer factor
26. Transfer of immunological information with dialysates of leukocyte extracts
27. A review of transfer factor immunotherapy in cancer
28. Prognosis in malignant melanoma of the skin—significance of stage of disease, anatomical site, sex, age and period of diagnosis
29. Staging of malignant melanomas by depth of invasion. A proposed index to prognosis
30. Malignant melanoma
31. Malignant melanoma. A clinical study of 427 cases
32. Effect of dialyzable transfer factor in patients with breast cancer
33. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens
34. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics
35. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma
36. Malignant melanoma. Role of node dissection reappraised
37. Zur Verlauf und Therapie der malignen Melanoma
38. Survival and regional disease control after isolation‐perfusion for invasive Stage I melanoma of the extremities
39. Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis
40. Therapie des malignant Melanoms der klinischen Stadien I und II. Ergebnisse bei 195 Patienten
41. Inefficacy of immediate node dissection in Stage I melanoma of the limbs
42. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage)